L. Jin

Gallstones and risk of cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohorts

A. Joshi, M. N. Kim, E. Giovannucci, 2022, British Journal of Cancer.

Induction with MEDA regimen and consolidation with Auto‐HSCT for stage IV NKTCL patients: A prospective multicenter study

Ligen Liu, S. Hao, Chuanxu Liu, 2022, International journal of cancer.

GELAD chemotherapy with sandwiched radiotherapy for patients with newly diagnosed stage IE/IIE natural killer/T‐cell lymphoma: a prospective multicentre study

H. Zhong, S. Hao, Chuanxu Liu, 2021, British journal of haematology.

1209P A phase II study of regorafenib in combination with nivolumab in patients with recurrent or metastatic solid tumors: Results of the ESCC cohort

B. Keam, I. Waxman, S. Pernot, 2022, Annals of Oncology.

46P AB521, a clinical-stage, potent, and selective Hypoxia-Inducible Factor (HIF)-2α inhibitor, for the treatment of renal cell carcinoma

F. Soriano, A. Mailyan, L. Seitz, 2022, Annals of Oncology.